Chappaqua, NY, United States of America

Roland Mertelsm


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Roland Mertelsm

Introduction

Roland Mertelsm is a notable inventor based in Chappaqua, NY (US). He has made significant contributions to the field of pharmacology, particularly in the development of human pluripotent hematopoietic preparations. His work has implications for the treatment of various hematological conditions.

Latest Patents

Mertelsm holds a patent for pharmacological preparations comprising human pluripotent hematopoietic colony-stimulating factor. This highly purified glycoprotein, with a molecular weight of 19,600, is produced by human tumor cells and has been purified from low serum-containing conditioned medium to apparent homogeneity. The pluripotent CSF supports the growth of human mixed colonies, granulocyte-macrophage colonies, and early erythroid colonies, while also inducing differentiation of human leukemic cells. The specific activity of the purified pluripotent CSF in the CFU-GM assay is 1.5 × 108 U/mg protein.

Career Highlights

Mertelsm is affiliated with the Sloan-Kettering Institute, where he has been able to further his research and innovations. His work has been instrumental in advancing the understanding of hematopoietic factors and their applications in medicine.

Collaborations

Throughout his career, Mertelsm has collaborated with esteemed colleagues such as Karl Welte and Erich Platzer. These collaborations have enriched his research and contributed to the advancement of the field.

Conclusion

Roland Mertelsm's contributions to pharmacology and his innovative patent highlight his role as a significant figure in the scientific community. His work continues to influence the development of treatments for hematological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…